Join the Conversation: Incorporating Breakthrough Cervical Cancer Data into Practice ,
an Industry Supported Symposium at IGCS 2023
Activity Overview
Seagen welcomes gynecologic oncologists, oncologists, advanced practitioners (NP/PA/PharmD), and other clinicians who treat patients with gynecologic malignancies to register for access to the Join the Conversation: Incorporating Breakthrough Cervical Cancer Data into Practice Enduring Education Materials, an Industry Supported Symposium by Seagen at the IGCS 2023 Annual Global Meeting in Seoul, South Korea.
Join us for an engaging symposium where leading experts will review the latest developments shaping the cervical cancer treatment landscape. Faculty will explore how recent breakthroughs are impacting real-world treatment, with case studies and perspectives on integrating new agents into practice. The highlights of the session will include a lively fireside chat discussion where the audience can engage with faculty on topics like managing side effects, patient selection, and access considerations. Throughout the symposium, attendees will have opportunities to participate through audience response technology and questions. You’ll leave with clinically relevant insights to help interpret the latest cervical cancer research and apply it to improve patient care.
This session is not included in the main event CME/CPD credit.
Target Audience
The target audience for this activity is community and academic gynecologic oncologists, oncologists, advanced practitioners (NP/PA/PharmD), and other providers who treat patients with gynecologic malignancies.
Learning Objectives
Upon completion of the activities in this series, learners will demonstrate:
-
- Review recent clinical trial data for early stage and recurrent cervical cancer.
- Discuss how emerging therapies are changing the treatment landscape for cervical cancer.
- Examine real-world case studies and expert perspectives on integrating new therapies into clinical practice.
Moderator
Dr. Keiichi Fujiwara
Faculty
Dr. Domenica Lorusso
Dr. Ana Oaknin
Dr. Leslie Randall
Dr. Brian Slomovitz
Agenda & Presentation Materials
Join the Conversation: Incorporating Breakthrough Cervical Cancer Data into Practice, an Industry Supported Symposium by Seagen at the IGCS 2023 Annual Global Meeting.
Presented on Sunday, November 5, 2023 from 12:40 – 14:10 KIST.
Enduring Education Materials will be available until August 2024.
Keiichi Fujiwara, MD, PhD, Saitama Medical University International Medical Center, Japan
Domenica Lorusso, MD, PhD, Fondazione Policlinico Gemelli IRCCS, Italy
Keiichi Fujiwara, MD, PhD, Saitama Medical University International Medical Center, Japan
Leslie Randall, MD, Massey Cancer Center, Virginia Commonwealth University, USA
Ana Oaknin, MD, PhD, Vall d´Hebron University Hospital, Vall d´Hebron Institute of Oncology, Spain
Brian Slomovitz, MD, Mount Sinai Medical Center, USA
All Faculty
Keiichi Fujiwara, MD, PhD, Saitama Medical University International Medical Center, Japan
Technical Requirements
For those participating virtually, this activity is best experienced using the most current browser (or one back) of Firefox, Chrome, Safari, Internet Explorer, or Microsoft Edge. For all activities featuring audio you must have a sound card and speakers.
SEAGEN and its logos are trademarks of Seagen Inc., registered in the European Union and elsewhere. ©2023 Seagen Inc. USA. All rights reserved.
Date of preparation: September 2023 | Merlen Number ASP/TVM/2023/0009